Literature DB >> 6356174

Behavioral and pharmacological aspects of opioid dependence: mixed agonist-antagonists.

W L Woolverton, C R Schuster.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6356174

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  7 in total

1.  Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.

Authors:  Torbjörn U C Järbe; Brian J LeMay; Aneetha Halikhedkar; JodiAnne Wood; Subramanian K Vadivel; Alexander Zvonok; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2013-09-05       Impact factor: 4.530

2.  Secondary reinforcing effects of opiate agonists in mice.

Authors:  E E Zvartu; V S Kovalenko
Journal:  Neurosci Behav Physiol       Date:  1987 Sep-Oct

3.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390.

Authors:  M S Kleven; E W Anthony; L I Goldberg; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Effects of several benzodiazepines, alone and in combination with flumazenil, in rhesus monkeys trained to discriminate pentobarbital from saline.

Authors:  W L Woolverton; M A Nader
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

6.  Effects of nimodipine on the discriminative stimulus properties of d-amphetamine in rats.

Authors:  P Nencini; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  A beta-carboline antagonizes benzodiazepine actions but does not precipitate the abstinence syndrome in cats.

Authors:  E Ongini; M Marzanatti; F Bamonte; A Monopoli; V Guzzon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.